With more than 12% of Americans on weight loss drugs like Ozempic and Mounjaro, metro Atlanta restaurants are changing the ...

This was exactly what I wanted, but I wanted this over three months. But every time I looked in the mirror, my body was ...

Do you know what it’s like to bleed every day for almost two years? I do, unfortunately. In the fall of 2023, I started to notice that my period—normally a blessedly predictable, brief three- or ...

A new systematic review and meta-analysis suggests that increasing (and maintaining) step counts to around 8,500 steps a day is helpful for maintaining significant weight loss long term. Experts say ...

Former UFC bantamweight champion T.J. Dillashaw was inside Khamzat Chimaev‘s camp for UFC 328 and says what happened during fight week was far more alarming than what played out publicly. Speaking ...

Rumors about the astonishing weight loss potential of Eli Lilly's triple hormone drug retatrutide have been circulating for months. The results of its Phase 3 clinical trial, just released by the ...

For decades, people have been told that their weight problems can be solved by math: Calories in, calories out. If weight were a simple math equation, more people would likely be the weight they ...

Eli Lilly on May 21 said its experimental weight-loss shot retatrutide delivered dramatic weight loss in a late-stage study of people with obesity. Lilly said people on the next-generation weight loss ...

Retatrutide, a powerful experimental weight-loss drug that mimics three different hormones the body produces after eating, helped people lose 70 pounds on average, or 28% of their body weight, ...

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these ...

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said. By Gina Kolata and Rebecca Robbins An experimental shot helped participants ...

The next generation of glucagonlike peptide 1 (GLP-1) weight-loss drugs has taken another step forward to U.S. Food and Drug Administration approval. In new clinical trial results from the ...